Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement

Bleiziffer, Sabine; Ali, Ayyaz; Hettich, Ina M.; Akdere, Deniz; Laubender, Rñ/4diger P.; Ruzicka, Daniel; Boehm, Johannes; Lange, Rñ/4diger; Eichinger, Walter
June 2010
Heart;Jun2010, Vol. 96 Issue 11, p865
Academic Journal
Background There has been ongoing controversy as to whether prosthesis-patient mismatch (PPM, defined as indexed effective orifice area (EOAI) <0.85 m²cm²) influences mortality after aortic valve replacement (AVR). In most studies, PPM is anticipated by reference tables based on mean EOAs as opposed to individual assessment. These reference values may not reflect the actual in vivo EOAI and hence, the presence or absence of PPM may be based on false assumptions. Objective To assess the impact of small prosthesis EOA on survival after aortic valve replacement AVR. Methods 645 patients had undergone an AVR between 2000 and 2007 entered the study. All patients underwent transthoracic echocardiography for determination of the actual EOAI within 6 months postoperatively. In order to predict time from surgery to death a proportional hazards model for competing risks (cardiac death vs death from other causes) was used. EOAI was entered as a continuous variable. Results PPM occurred in 40% of the patients. After a median follow-up of 2.35 years, 92.1% of the patients were alive. The final Cox regression model showed a significantly increased risk for cardiac death among patients with a smaller EOAI (HR=0.32, p=0.022). The effect of EOAI on the 2-5 year mortality risk was demonstrated by risk plots. Conclusions In contrast to previous studies these EOAI values were obtained through postoperative echocardiography, substantially improving the accuracy of measurement, and the EOAI was modelled as a continuous variable. There was a significantly improved survival for larger EOAIs following AVR. Strategies to avoid PPM should become paramount during AVR.


Related Articles

  • Does the transapical approach impair early recovery of systolic strain following transcatheter aortic valve replacement? Ando, Tomo; Holmes, Anthony A.; Taub, Cynthia C.; DeRose, Joseph J.; Slovut, David P. // American Journal of Cardiovascular Disease;2015, Vol. 5 Issue 2, p110 

    Background: In transcatheter aortic valve replacement (TAVR) the trans-apical approach (TA) is associated with apical myocardial injury but it is unknown if this injury impacts myocardial function. This study was performed to assess the impact of TA on apical longitudinal strain (ALS) and global...

  • CoveValve completes ReValving system cases.  // Medical Device Daily;9/12/2008, Vol. 12 Issue 196, p3 

    The article reports on the announcement by CoreCalve of the completion of the first series of proctored cases using the company's proprietary ReValving system for percutaneous aortic valve replacement, featuring a porcine pericardium valve mounted in a self-expanding frame. The trials were...

  • Aortic Valve Replacement in Older Adults: Mechanical or Bioprosthetic Valve? Boyle, Andrew J. // Clinical Cardiology Alert;Jun2013, Vol. 32 Issue 6, p43 

    The article discusses the decision to choose a mechanical or a tissue valve for patients undergoing surgical aortic valve replacement (AVR). It mentions that researcher Brennan and colleagues searched the Society of Thoracic Surgeons (STS) database and identified a cohort of Medicare-linked...

  • TVT Registry confirms real-world benefits of TAVR.  // Cardiology Today;May2014, Vol. 17 Issue 5, p20 

    The article discusses research being done on the outcomes of transcatheter aortic valve replacement in U.S. patients, which references a study by David R. Holes et al. presented at the 2014 American College of Cardiology (ACC) Scientific Sessions.

  • Transcatheter aortic valve implantation (TAVI): risky and costly. Van Brabandt, Hans; Neyt, Mattias; Hulstaert, Frank // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/4/2012, Vol. 345 Issue 7868, p24 

    The article discusses the use of transcatheter aortic valve implantation (TAVI) as a form of treatment for patients with a life threatening heart condition. However, several doubts still remain with regards to the cost effectiveness and clinical outcomes of TAVI. Rigorous analysis of available...

  • Transcatheter heart valve implantation.  // British Journal of Hospital Medicine (17508460);Oct2010, Vol. 71 Issue 10, p549 

    The article reports on the publication of results of the first randomized controlled trial of a transcatheter aortic heart valve in the periodical "New England Journal of Medicine."

  • Transcatheter aortic valve and valve-in-valve implantation in a beating stenotic porcine aortic valve: intracardiac endoscopic view†. Gelpi, Guido; Romagnoni, Claudia; Vismara, Riccardo; Antona, Carlo // European Journal of Cardio-Thoracic Surgery;Dec2014, Vol. 46 Issue 6, p1037 

    Several photographs are presented which depict a CoreValve implantation in a bicuspid stenotic porcine aortic valve, a CoreValve step-by-step implantation in a stenotic beating porcine aortic valve, and a valve-in-valve procedure.

  • Aortic Root Infection Destroying the Left Fibrous Trigone. Posacioglu, Hakan; Apaydin, Anil; Degirmenciler, Kenan; Ozbaran, Mustafa; Stainback, Raymond F. // Texas Heart Institute Journal;2005, Vol. 32 Issue 1, p110 

    Presents the case of a 28-year old man with endocarditis following mitral and aortic valve replacement with a mechanical prosthesis. Medical history of the patient; Role of a polytetrafluoroethylene patch in mitral annulus and mitral prosthesis; Surgical technique of choice when aortic-mitral...

  • Transapical off-pump aortic valve-in-a-valve implantation in two elderly patients with a degenerated porcine bioprosthesis Maroto, Luis C.; Rodríguez, José E.; Cobiella, Javier; Marcos, Pedro // European Journal of Cardio-Thoracic Surgery;Mar2010, Vol. 37 Issue 3, p738 

    Abstract: Re-operative heart-valve replacement is a high-risk procedure and even more so in elderly patients. Another option in high-risk patients with a degenerated aortic xenograft is the implant of a second aortic bioprosthesis using a transcatheter approach. We report two cases of patients...


Read the Article


Sign out of this library

Other Topics